top
Search terms
Results 223221 - 223230 of 223369 - ordered by :
Pages: 1 ... 22320 22321 22322 22323 22324 22325 22326 ... 22337
Escardio

Acute CardiovascalureCare Congress 2019 State of the Art lecture: present and future of antithrombotic strategies after TAVR ESC congress 2018 Maintenance of anti-thrombotic therapy after TAVI ...

Date : 10/06/2019
ESC365

Ticagrelor vs prasugrel in acute phase of primary percutaneous coronary intervention under treatment with abciximab: safety and efficacy

Date : 02/03/2019
ESC365

Left ventricular ejection fraction and adjudicated, cause-specific hospitalizations after myocardial infarction complicated by heart failure or left ventricular dysfunction

Date : 28/08/2018
ESC365

Meet the Experts - Safety first: avoiding adverse events with new cardiovascular drugs

Date : 26/08/2018
ESC365

Antiplatelet therapy use in atrial fibrillation patients taking oral anticoagulation: an analysis of adverse outcomes from the FANTASIIA registry.

Date : 26/08/2018
ESC365

Estimated effectiveness and safety of non-vitamin K antagonist oral anticoagulants compared to optimally anticoagulated real-world atrial fibrillation patients taking acenocoumarol

Date : 27/08/2018
ESC365

Is there an obesity paradox for adverse outcomes in patients with atrial fibrillation? insights from the FANTASIIA registry

Date : 25/08/2018
Date : 28/08/2018
ESC365

Performance of the Cockcroft-Gault, MDRD and CKD-EPI Formulae in Atrial Fibrillation patients.The FANTASIIA Registry.

Date : 27/08/2018
Escardio

In this regard, a recent trial of postconditioning in 1,234 patients undergoing PCI failed to reduce the composite outcome of death from any cause and hospitalization for heart failure. (4) In 2015, ...

Date : 27/05/2019